Q1 preview: US growth likely to boost pharma sector’s performance
The drug companies’ performance in the first quarter of fiscal 2022-2023 will be largely supported by US sales, new launches,
Continue reading
Tag: Covid proceeds
The Number One Finance & Business Blog!